CAT No: AAD-335
CAS No:203866-21-1
Synonyms/Alias:203866-21-1;Fmoc-4,4-difluoro-L-Proline;(2s)-fmoc-4,4-difluoro-pyrrolidine-2-carboxylic acid;(S)-1-(((9H-Fluoren-9-yl)methoxy)carbonyl)-4,4-difluoropyrrolidine-2-carboxylic acid;(2S)-1-(9H-fluoren-9-ylmethoxycarbonyl)-4,4-difluoropyrrolidine-2-carboxylic acid;(2S)-1-{[(9H-FLUOREN-9-YL)METHOXY]CARBONYL}-4,4-DIFLUOROPYRROLIDINE-2-CARBOXYLIC ACID;MFCD01860709;(2S)-1-(((9H-fluoren-9-yl)methoxy)carbonyl)-4,4-difluoropyrrolidine-2-carboxylic acid;(2S)-1-[(9H-fluoren-9-ylmethoxy)carbonyl]-4,4-difluoropyrrolidine-2-carboxylic acid;n-fmoc-4,4-difluoroproline;Fmoc-L-4,4-difluoroproline;Fmoc-Pro(4,4-F2)-OH;SCHEMBL3469506;1-Fmoc-4,4-difluoro-L-proline;DTXSID30453227;(2S)-1-{[(9H-FLUOREN-9-YL)METHOXY]CARBONYL-4,4-DIFLUOROPYRROLIDINE-2-CARBOXYLIC ACID;AKOS026739631;FF54791;FS-6608;CS-0046367;EN300-321106;P17967;1-{[(9H-Fluoren-9-yl)methoxy]carbonyl}-4,4-difluoro-L-proline;(S)-1-(((9H-Fluoren-9-yl)methoxy)carbonyl)-4,4-difluoropyrrolidine-2-carboxylicacid;1,2-Pyrrolidinedicarboxylicacid,4,4-difluoro-,1-(9H-fluoren-9-ylmethyl)ester,(2S)-;819-466-9;
1. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy
4. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.